GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » Notes Receivable

Chandra Bhagat Pharma (BOM:542934) Notes Receivable : ₹0 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma Notes Receivable?

Chandra Bhagat Pharma's Notes Receivable for the quarter that ended in Sep. 2023 was ₹0 Mil.


Chandra Bhagat Pharma Notes Receivable Historical Data

The historical data trend for Chandra Bhagat Pharma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma Notes Receivable Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Chandra Bhagat Pharma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Chandra Bhagat Pharma Notes Receivable Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Chandra Bhagat Pharma (BOM:542934) Business Description

Traded in Other Exchanges
N/A
Address
Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma (BOM:542934) Headlines

No Headlines